Shares of Vertex Pharmaceuticals Inc. VRTX advanced 1.11% to $491.64 Wednesday, on what proved to be an all-around favorable ...
With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston ...
One of the planned studies evaluating the impact of the proposed Buc-ee's west of I-25 off County Line Road shows 2025 ...
Wedbush reaffirmed its “outperform” rating on Palantir Technologies, setting a $120 price target. Other analysts also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback